Unnamed: 0,title,date,stock,sentiment
225663.0,"The Daily Biotech Pulse: Keytruda Setback For Merck, Denali Pulls The Plug On Neurological Asset",2020-06-10 07:30:00-04:00,CDNA,positive
225664.0,CareDx Reports $100M Common Stock Offering,2020-06-09 17:14:00-04:00,CDNA,neutral
225665.0,CareDx Reports Its AlloSeq Tx 17 Wins CE Mark Approval,2020-05-15 07:10:00-04:00,CDNA,positive
225666.0,UPDATE: CareDx Will Become Exclusive Worldwide Commercialization Partner For Solid Organ Transplant-rejection Tests On Veracyte's Diagnostic Platform,2020-05-14 08:18:00-04:00,CDNA,positive
225667.0,CareDx And Veracyte Announce Exclusive Partnership For Transplant Rejection Testing On nCounter System,2020-05-14 08:17:00-04:00,CDNA,negative
225668.0,CareDx Collaborates With Weill Cornell Medicine To Lead Development And Commercialization Of UroMap,2020-05-05 07:21:00-04:00,CDNA,neutral
225669.0,"HC Wainwright & Co. Reiterates Buy on CareDx, Lowers Price Target to $40",2020-05-01 07:28:00-04:00,CDNA,negative
225670.0,"CareDx Q1 EPS $0.00 Misses $0.03 Est., Sales $38.400M Beat $37.990M Estimate",2020-04-30 16:14:00-04:00,CDNA,negative
225671.0,"The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Hologic To Launch Coronavirus Test, Amarin's Strong Q1",2020-04-30 07:19:00-04:00,CDNA,positive
225672.0,"The Week Ahead In Biotech (April 26-May 2): Cancer Conference, Earnings News Flow In The Spotlight",2020-04-26 16:37:00-04:00,CDNA,negative
225673.0,CareDx CEO Says Pandemic Proves Value Of Remote Transplant Monitoring System,2020-04-21 17:05:00-04:00,CDNA,positive
225674.0,"The Daily Biotech Pulse: FDA Nod For Pfizer, Vanda Forges Partnership For COVID-19 Drug Research, Neuronetics Pre-Announces Revenue Shortfall",2020-04-09 07:52:00-04:00,CDNA,neutral
225675.0,CareDx Reports Collaboration With Quest Diagnostics' ExamOne To Expand Mobile Phlebotomy Coverage Across US,2020-04-09 07:03:00-04:00,CDNA,positive
225676.0,CareDx Sees Prelim. Q1 Sales $38.3M vs $37.76M Est.,2020-04-08 16:02:00-04:00,CDNA,neutral
225677.0,CareDx Announces New AJT Publication: AlloSure Monitors First Patient Retransplanted After Anti-PD-L1 Cancer Therapy,2020-03-20 05:25:00-04:00,CDNA,negative
225678.0,"The Daily Biotech Pulse: AbbVie, Allergan Agree On Divestments, Obalon Stops Obesity Balloon Sale, COVID-19 Updates",2020-03-18 07:36:00-04:00,CDNA,positive
225679.0,CareDx Launches RemoTraC Home-Based Monitoring Of Transplant Patients,2020-03-17 07:06:00-04:00,CDNA,neutral
225680.0,Stocks That Hit 52-Week Lows On Thursday,2020-03-12 12:10:00-04:00,CDNA,negative
225681.0,92 Biggest Movers From Yesterday,2020-03-05 04:41:00-05:00,CDNA,neutral
225682.0,60 Stocks Moving In Wednesday's Mid-Day Session,2020-03-04 12:11:00-05:00,CDNA,neutral
225683.0,CareDx Sees FY20 Sales $165M-$168M Vs $170.42M Estimate,2020-02-27 16:27:00-05:00,CDNA,neutral
225684.0,"CareDx Q4 EPS $0.04 Beats $0.01 Estimate, Sales $35.8M Beat $35.78M Estimate",2020-02-27 16:26:00-05:00,CDNA,neutral
225685.0,"The Daily Biotech Pulse: Gilead Kicks Off Coronavirus Drug Trials, Adcom Nod For Lily, FDA Approves Esperion's Lipid-Lowering Adjunctive Combo Therapy",2020-02-27 07:35:00-05:00,CDNA,positive
225686.0,The Week Ahead In Biotech: Biopharma Earnings Pick Up Pace,2020-02-23 18:38:00-05:00,CDNA,neutral
225687.0,Natera Reports Filed Suit Against CareDx For False Advertising In US District Court For Delaware,2020-02-18 09:23:00-05:00,CDNA,neutral
225688.0,CareDx's Patent Rights Upheld By Delaware Court,2020-02-11 07:12:00-05:00,CDNA,neutral
225689.0,13 Diagnostics & Research Stocks Moving In Monday's Session,2020-01-27 12:40:00-05:00,CDNA,neutral
225690.0,21 Diagnostics & Research Stocks Moving In Thursday's Session,2020-01-23 12:53:00-05:00,CDNA,neutral
225691.0,17 Diagnostics & Research Stocks Moving In Tuesday's Session,2020-01-21 14:42:00-05:00,CDNA,neutral
225692.0,85 Biggest Movers From Yesterday,2020-01-14 04:52:00-05:00,CDNA,neutral
225693.0,41 Stocks Moving In Monday's Mid-Day Session,2020-01-13 12:21:00-05:00,CDNA,neutral
225694.0,CareDx Sees Q4 Sales $35.7M-36M vs $34.15M Est,2020-01-13 07:57:00-05:00,CDNA,neutral
225695.0,CareDx Raises FY2019 Sales Guidance from $124M-125M to $127M-127.3M,2020-01-13 07:57:00-05:00,CDNA,neutral
225696.0,CareDx Reports AlloSeq cfDNA Wins CE Mark Approval,2020-01-10 07:03:00-05:00,CDNA,positive
225697.0,CareDx Says Judge Has Issued Report Recommending US District Court In Delaware Reject Natera's Motion To Dismiss Co.'s False Advertising Complaint,2020-01-08 07:09:00-05:00,CDNA,negative
225698.0,"The Daily Biotech Pulse: Roche-Spark Deal Extended Again, Zymeworks' Positive Readout, Enanta Misses Earnings Estimate",2019-11-22 08:18:00-05:00,CDNA,positive
225699.0,46 Biggest Movers From Yesterday,2019-11-05 04:45:00-05:00,CDNA,neutral
225700.0,35 Stocks Moving In Monday's Mid-Day Session,2019-11-04 13:37:00-05:00,CDNA,neutral
225701.0,58 Biggest Movers From Friday,2019-11-04 07:12:00-05:00,CDNA,neutral
225702.0,50 Stocks Moving In Friday's Mid-Day Session,2019-11-01 13:09:00-04:00,CDNA,neutral
225703.0,CareDx shares are trading lower after the company issued FY19 sales guidance below analyst estimates.,2019-11-01 10:11:00-04:00,CDNA,neutral
225704.0,"The Daily Biotech Pulse: Amgen Takes 20.5% Stake In BeiGene, Paratek's Mixed Clinical Readout, CareDx Slips On Guidance",2019-11-01 07:38:00-04:00,CDNA,neutral
225705.0,CareDx shares are trading lower after the company issued FY19 sales guidance below analyst estimates.,2019-10-31 16:50:00-04:00,CDNA,neutral
225706.0,CareDx Narrows FY19 Sales Guidance From $123M-$125M To $124M-$125M vs $125.5M Estimate,2019-10-31 16:25:00-04:00,CDNA,neutral
225707.0,"CareDx Q3 EPS $0.02 Beats $0.01 Estimate, Sales $33.8M Beat $33.14M Estimate",2019-10-31 16:24:00-04:00,CDNA,neutral
225708.0,"Craig-Hallum Initiates Coverage On CareDx with Buy Rating, Announces $48 Price Target",2019-10-01 10:49:00-04:00,CDNA,neutral
225709.0,CareDx Files Patent Infringement Lawsuit Against Eurofins Viracor,2019-09-26 09:26:00-04:00,CDNA,negative
225710.0,CareDx Enrolls First Patient In OKRA Registry,2019-09-18 08:04:00-04:00,CDNA,neutral
225711.0,CareDx Acquires XynManagement; Terms Not Disclosed,2019-08-28 08:07:00-04:00,CDNA,neutral
225712.0,CMS Issues Draft Coverage Determination Expanding AlloSure Medicare Coverage For Testing In Heart And Kidney Transplant REcipients,2019-08-22 11:11:00-04:00,CDNA,positive
225713.0,70 Biggest Movers From Yesterday,2019-08-06 04:46:00-04:00,CDNA,neutral
225714.0,"Raymond James Maintains Strong Buy on CareDx, Raises Price Target to $48",2019-08-02 12:27:00-04:00,CDNA,positive
225715.0,28 Healthcare Stocks Moving In Today's Pre-Market Session,2019-08-02 09:07:00-04:00,CDNA,neutral
225716.0,48 Stocks Moving In Friday's Pre-Market Session,2019-08-02 08:19:00-04:00,CDNA,neutral
225717.0,40 Healthcare Stocks Moving In Thursday's After-Market Session,2019-08-02 04:10:00-04:00,CDNA,neutral
225718.0,"The Daily Biotech Pulse: Exelixis Signs Cancer Drug Licensing Deal, Adamis Offering, Surmodics Surges On Earnings",2019-08-01 07:18:00-04:00,CDNA,negative
225719.0,40 Healthcare Stocks Moving In Friday's After-Market Session,2019-07-29 04:25:00-04:00,CDNA,neutral
225720.0,"The Week Ahead In Biotech: Pending Clinical Readouts, Earnings Dominate",2019-07-27 14:32:00-04:00,CDNA,negative
225721.0,35 Healthcare Stocks Moving In Wednesday's After-Market Session,2019-07-25 05:55:00-04:00,CDNA,neutral
225722.0,58 Biggest Movers From Yesterday,2019-07-17 04:59:00-04:00,CDNA,neutral
225723.0,41 Stocks Moving In Tuesday's Mid-Day Session,2019-07-16 12:10:00-04:00,CDNA,neutral
225724.0,"CareDx shares are trading lower after Kerrisdale Capital announced a sport position in the stock, saying it believes the company's pivotal kidney transplant test is 'headed for rejection.'",2019-07-16 10:03:00-04:00,CDNA,neutral
225725.0,"Kerrisdale Capital Releases Short Position In CareDx, Says 'Pivotal Kidney Transplant Test Headed for Rejection'",2019-07-16 10:01:00-04:00,CDNA,negative
225726.0,48 Biggest Movers From Yesterday,2019-07-10 06:35:00-04:00,CDNA,neutral
225727.0,30 Stocks Moving In Tuesday's Mid-Day Session,2019-07-09 12:12:00-04:00,CDNA,neutral
225728.0,CareDx Receives New Transplant Patent Entitled 'Non-invasive diagnosis of graft rejection in organ transplant patients',2019-06-26 08:20:00-04:00,CDNA,negative
225729.0,"The Daily Biotech Pulse: DiaMedica Reports Positive Data For Chronic Kidney Disease Drug, Eloxx Offering, IPO Deluge",2019-06-20 07:25:00-04:00,CDNA,positive
225730.0,82 Biggest Movers From Yesterday,2019-05-10 06:27:00-04:00,CDNA,neutral
225731.0,71 Stocks Moving In Thursday's Mid-Day Session,2019-05-09 12:11:00-04:00,CDNA,neutral
225732.0,8 Biggest Price Target Changes For Thursday,2019-05-09 09:45:00-04:00,CDNA,neutral
225733.0,"Benzinga's Top Upgrades, Downgrades For May 9, 2019",2019-05-09 09:07:00-04:00,CDNA,positive
225734.0,CareDx shares are trading higher after the company reported better-than-expected Q1 EPS and sales results. The company also raised its FY19 sales guidance.,2019-05-09 09:04:00-04:00,CDNA,positive
225735.0,"H.C. Wainwright Upgrades CareDx, Inc. - Common Stock to Buy, Raises Price Target to $43",2019-05-09 08:12:00-04:00,CDNA,neutral
225736.0,"The Daily Biotech Pulse: Novartis Goes Shopping, Mixed Trial Results For Provention Bio, 4 Stocks To Debut",2019-05-09 07:56:00-04:00,CDNA,neutral
225737.0,CareDx shares are trading higher after the company reported better-than-expected Q1 EPS and sales results; the company also raised FY19 sales guidance.,2019-05-08 16:08:00-04:00,CDNA,positive
225738.0,CareDx Raises FY19 Sales Guidance From $105M-$107M To $113M-$115M vs $106.32M Est.,2019-05-08 16:03:00-04:00,CDNA,neutral
225739.0,"CareDx Q1 Adj. EPS $0.05 Beats $(0.03) Estimate, Sales $26M Beat $24.3M Estimate",2019-05-08 16:02:00-04:00,CDNA,neutral
225740.0,"The Daily Biotech Pulse: Daiichi's Positive Breast Cancer Trial, Supernus Slumps, Axovant Reverse Split",2019-05-08 07:53:00-04:00,CDNA,negative
225741.0,48 Biggest Movers From Friday,2019-04-29 05:43:00-04:00,CDNA,neutral
225742.0,CareDx To Acquire OTTR Complete Transplant Management For $16M,2019-04-25 16:55:00-04:00,CDNA,neutral
225743.0,Shares of several drug companies are trading lower amid continued efforts from Washington to curb prescription drug prices. The overall healthcare sector has seen weakness recently due to uncertainty over the future of healthcare policy.,2019-04-17 10:31:00-04:00,CDNA,negative
225744.0,52 Biggest Movers From Yesterday,2019-04-05 05:55:00-04:00,CDNA,neutral
225745.0,44 Stocks Moving In Thursday's Mid-Day Session,2019-04-04 12:39:00-04:00,CDNA,neutral
225746.0,CareDx Reports Filing Of Patent Infringement Suit Against Natera,2019-03-26 09:18:00-04:00,CDNA,negative
225747.0,"The Daily Biotech Pulse: Immutep Gets US Patent, Conatus NASH Disappointment, Eisai Moves On After Aducanumab Setback",2019-03-22 08:16:00-04:00,CDNA,negative
225748.0,"The Daily Biotech Pulse: KaryoPharm's Selinexor Review Delayed, FDA Accepts Adamis Opioid Overdose Drug NDA",2019-03-15 07:39:00-04:00,CDNA,positive
225749.0,"The Daily Biotech Pulse: Arsanis Completes X4 Merger, EC Nod For Roche, Axovant Offering",2019-03-14 07:47:00-04:00,CDNA,neutral
225750.0,CareDx Announces That Cedars-Sinai Comprehensive Transplant Center Has Used AlloSure In A Tocilizumab Trial,2019-03-13 08:05:00-04:00,CDNA,positive
225751.0,"The Daily Biotech Pulse: AEterna Zentaris Explores Options, Verastem Plunges On Weak Copiktra Sales, FDA Nod For Aerie",2019-03-13 07:27:00-04:00,CDNA,negative
225752.0,"The Daily Biotech Pulse: Tonix Gets European Patent, EC Nod For Roche, Insys Earnings",2019-03-08 07:38:00-05:00,CDNA,neutral
225753.0,64 Biggest Movers From Yesterday,2019-03-08 05:22:00-05:00,CDNA,neutral
225754.0,51 Stocks Moving In Thursday's Mid-Day Session,2019-03-07 12:32:00-05:00,CDNA,neutral
225755.0,CareDx shares are trading higher after the company reported better-than-expected Q4 EPS and sales; the company also provided FY19 sales guidance above analyst estimates.,2019-03-07 10:42:00-05:00,CDNA,positive
225756.0,"Daily Biotech Pulse: Allergan's Depression Drug Flunks Late-Stage Trial, Apellis Offering, ShockWave Medical IPO",2019-03-07 07:48:00-05:00,CDNA,negative
225757.0,CareDx Sees FY19 Sales $105M-$107M vs $103.6M Est.,2019-03-06 16:06:00-05:00,CDNA,neutral
225758.0,"CareDx Q4 Adj. EPS $0.01 Beats $(0.02) Estimate, Sales $23.5M Beat $22.73M Estimate",2019-03-06 16:06:00-05:00,CDNA,neutral
225759.0,"The Daily Biotech Pulse: Horizon Pharma Under DoJ Radar, FDA Greenlights J&J's Depression Drug, Endologix Reverse Split",2019-03-06 07:39:00-05:00,CDNA,negative
225760.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings, IPOs",2019-03-03 09:41:00-05:00,CDNA,neutral
225761.0,"The Daily Biotech Pulse: Bristol-Myers Squibb-Celgene Deal Faces Setback, Syneos Hit By SEC Probe, FDA Cheer For T2 Biosystems",2019-02-28 08:24:00-05:00,CDNA,positive
225762.0,61 Biggest Movers From Friday,2019-02-19 05:14:00-05:00,CDNA,neutral
225763.0,"Benzinga's Top Upgrades, Downgrades For February 15, 2019",2019-02-15 09:16:00-05:00,CDNA,positive
225764.0,"Jefferies Initiates Coverage On CareDx with Buy Rating, Announces $35 Price Target",2019-02-15 07:52:00-05:00,CDNA,neutral
225765.0,56 Biggest Movers From Yesterday,2019-01-15 04:57:00-05:00,CDNA,neutral
225766.0,44 Biggest Movers From Friday,2019-01-14 04:46:00-05:00,CDNA,neutral
225767.0,CareDx Sees Q4 Sales $23.2M-$23.5M vs $21.78M Est.,2019-01-07 08:13:00-05:00,CDNA,neutral
225768.0,58 Biggest Movers From Friday,2019-01-07 04:17:00-05:00,CDNA,neutral
225769.0,41 Stocks Moving In Friday's Mid-Day Session,2019-01-04 12:17:00-05:00,CDNA,neutral
225770.0,"Stocks Which Set New 52-Week High Yesterday, Mon., Dec. 3, 2018",2018-12-04 09:20:00-05:00,CDNA,neutral
225771.0,CareDx Announces Full Repayment Of Its Outstanding Debt,2018-11-26 08:05:00-05:00,CDNA,positive
225772.0,64 Biggest Movers From Yesterday,2018-11-16 04:58:00-05:00,CDNA,neutral
225773.0,45 Stocks Moving In Thursday's Mid-Day Session,2018-11-15 12:38:00-05:00,CDNA,neutral
225774.0,"The Daily Biotech Pulse: Mallinckrodt Faces FDA Panel, Reshape's Earnings, Vapotherm To Debut",2018-11-14 08:17:00-05:00,CDNA,neutral
225775.0,CareDx Announces Prices 2M Share Public Offering of Common Stock @$24.50/Share,2018-11-14 04:10:00-05:00,CDNA,positive
225776.0,CareDx Reports 2M Share Common Stock Offering,2018-11-13 16:05:00-05:00,CDNA,positive
225777.0,85 Biggest Movers From Friday,2018-11-12 05:16:00-05:00,CDNA,neutral
225778.0,68 Stocks Moving In Friday's Mid-Day Session,2018-11-09 12:42:00-05:00,CDNA,neutral
225779.0,"Stocks Which Set New 52-Week High Yesterday, Thurs., Nov. 8, 2018",2018-11-09 09:38:00-05:00,CDNA,neutral
225780.0,34 Stocks Moving In Friday's Pre-Market Session,2018-11-09 08:15:00-05:00,CDNA,neutral
225781.0,"The Daily Biotech Pulse: SITC Presentations Pick Up Pace, Sandoz' Voluntary Recall",2018-11-09 07:32:00-05:00,CDNA,neutral
225782.0,CareDx Raises FY18 Sales $68M-$70M To $74M-$75M vs $69M Est.,2018-11-08 16:27:00-05:00,CDNA,neutral
225783.0,"CareDx Q3 EPS $(0.01) Beats $(0.03) Estimate, Sales $21.2M Beat $18.47M Estimate",2018-11-08 16:27:00-05:00,CDNA,neutral
225784.0,"The Daily Biotech Pulse: Nantkwest Reports Positive Cancer Vaccine Trial Results, Sarepta Offering",2018-11-08 08:10:00-05:00,CDNA,negative
225785.0,"The Week Ahead In Biotech: Earnings, Conferences, PDUFA Dates, Clinical Trial Results And IPOs",2018-11-04 13:35:00-05:00,CDNA,neutral
225786.0,CareDx Shows Registration For $50M Common Stock Offering,2018-10-12 06:17:00-04:00,CDNA,neutral
225787.0,"Stocks Which Set New 52-Week High Yesterday, September 26th",2018-09-27 09:12:00-04:00,CDNA,neutral
225788.0,"The Daily Biotech Pulse: Hologic Goes Shopping, Johnson & Johnson Snaps Ties With Geron",2018-09-27 08:20:00-04:00,CDNA,neutral
225789.0,"Stocks Which Set New 52-Week High Yesterday, September 25th",2018-09-26 11:53:00-04:00,CDNA,neutral
225790.0,"The Daily Biotech Pulse: Verastem's Chinese Duvelisib Licensing Deal, Aldeyra's Positive Dry Eye Disease Drug Trial",2018-09-26 08:25:00-04:00,CDNA,positive
225791.0,"Stocks That Made New 52-Week Highs Yesterday, September 6th",2018-09-07 16:47:00-04:00,CDNA,neutral
225792.0,"Stocks Which Set New 52-Week High Yesterday, September 5th",2018-09-06 08:48:00-04:00,CDNA,neutral
225793.0,"The Daily Biotech Pulse: Novartis Divestment, Eyepoint's Drug Gets Coverage, Spectrum's Robust Data",2018-09-06 08:28:00-04:00,CDNA,positive
225794.0,"Stocks Which Set New 52-Week High Friday, August 31",2018-09-04 10:29:00-04:00,CDNA,neutral
225795.0,"Stocks Which Set New 52-Week High Yesterday, August 30th",2018-08-31 10:11:00-04:00,CDNA,neutral
225796.0,"The Daily Biotech Pulse: FDA Blessings for Merck's HIV Drug Combo, Veracyte's Test Gets Medicare Coverage",2018-08-31 08:29:00-04:00,CDNA,positive
225797.0,"Stocks Which Set New 52-Week High Yesterday, August 29th",2018-08-30 11:47:00-04:00,CDNA,neutral
225798.0,"The Daily Biotech Pulse: Verastem Gets New CFO, Mesoblast Earnings, Vertex's Precision Medicine Collaboration",2018-08-30 08:02:00-04:00,CDNA,neutral
225799.0,"Stocks Which Set New 52-Week High Yesterday, August 28th",2018-08-29 11:13:00-04:00,CDNA,neutral
225800.0,"Stocks Which Set New 52-Week High Friday, August 24th",2018-08-27 09:24:00-04:00,CDNA,neutral
225801.0,"Stocks Which Set New 52-Week High Yesterday, August 23rd",2018-08-24 09:11:00-04:00,CDNA,neutral
225802.0,"The Daily Biotech Pulse: Immunomedics' Bottom-Line Miss; Kala, Regeneron Await FDA Verdict",2018-08-24 08:47:00-04:00,CDNA,positive
225803.0,"Stocks Which Set New 52-Week High Yesterday, August 22nd",2018-08-23 10:51:00-04:00,CDNA,neutral
225804.0,"The Daily Biotech Pulse: Novartis Breast Cancer Trial Meets Endpoint, Medpace's Offering, Dexcom Buys TypeZero",2018-08-23 08:23:00-04:00,CDNA,negative
225805.0,50 Biggest Movers From Yesterday,2018-08-23 05:10:00-04:00,CDNA,neutral
225806.0,61 Biggest Movers From Friday,2018-08-13 06:43:00-04:00,CDNA,neutral
225807.0,60 Stocks Moving In Friday's Mid-Day Session,2018-08-10 13:27:00-04:00,CDNA,neutral
225808.0,CareDx shares are up 15.4% after the company beat Q2 EPS and sales estimates and raised 2018 sales guidance.,2018-08-10 10:35:00-04:00,CDNA,positive
225809.0,CareDx Late Thursday Announced FY18 Sales Guidance Raise From $64M-$66M To $68M-$70M vs $65.17M Est.,2018-08-10 10:34:00-04:00,CDNA,neutral
225810.0,"The Daily Biotech Pulse: Puma, CareDx Soar On Earnings, Corcept Plunges On Bottom-Line Miss",2018-08-10 07:38:00-04:00,CDNA,negative
225811.0,"CareDx Q2 EPS $(0.04) Beats $(0.07) Estimate, Sales $17.823M Beat $15.49M Estimate",2018-08-09 16:20:00-04:00,CDNA,neutral
225812.0,"The Daily Biotech Pulse: Ampio Slides On Offering, Sangamo's Positive Trial Results, Insys Earnings",2018-08-09 08:39:00-04:00,CDNA,positive
225813.0,Form 4 Filing Late Wednesday Showed CareDX Chief Commercial Officer Sold 9.458K Shares at $14.03,2018-08-02 13:57:00-04:00,CDNA,positive
225814.0,65 Biggest Movers From Yesterday,2018-08-01 04:36:00-04:00,CDNA,neutral
225815.0,44 Biggest Movers From Yesterday,2018-06-26 04:50:00-04:00,CDNA,neutral
225816.0,36 Stocks Moving In Monday's Mid-Day Session,2018-06-25 12:26:00-04:00,CDNA,neutral
225817.0,50 Biggest Movers From Friday,2018-06-25 05:46:00-04:00,CDNA,neutral
225818.0,CareDx Shares Down 22.8% Of ~6X Avg. Volume Despite Lack Of News Or Clear Catalyst To Justify Price Action; Watch For Technical Indicators And Profit Taking,2018-06-22 14:48:00-04:00,CDNA,positive
225819.0,40 Stocks Moving In Friday's Mid-Day Session,2018-06-22 12:14:00-04:00,CDNA,neutral
225820.0,"Benzinga's Daily Biotech Pulse: Johnson & Johnson to Dispose Sterilization Products Business, Mixed Results From Protesostasis' Cystic Fibrosis Study",2018-06-07 07:58:00-04:00,CDNA,neutral
225821.0,CareDx Shares Tick Slightly Higher Following 13G Filing From Alger Associates Showing New 10.49% Stake,2018-06-06 12:38:00-04:00,CDNA,positive
225822.0,"Benzinga's Daily Biotech Pulse: Vascular Biogenics Soars On Positive Platform Data, Axovant Licenses Parkinson's Candidate",2018-06-06 08:38:00-04:00,CDNA,positive
225823.0,45 Biggest Movers From Yesterday,2018-06-06 04:35:00-04:00,CDNA,neutral
225824.0,Benzinga's Daily Biotech Pulse: Organovo Falls On Earnings; Celgene Gets New CFO,2018-06-01 08:16:00-04:00,CDNA,neutral
225825.0,"Benzinga's Daily Biotech Pulse: Clinical Hold For Crispr, Gilead Study Meets Endpoint, Akers Gets Grace Time",2018-05-31 08:22:00-04:00,CDNA,positive
225826.0,CareDx Sees FY18 Sales $64M-$66M vs $61.36M Est.,2018-05-10 16:49:00-04:00,CDNA,neutral
225827.0,"CareDx Q1 Adj. EPS $(0.14) Misses $(0.13) Estimate, Sales $14.05M Beat $13.3M Estimate",2018-05-10 16:48:00-04:00,CDNA,negative
225828.0,"Benzinga's Daily Biotech Pulse: ARMO Skyrockets On Eli Lilly Deal, Akcea Meets FDA Panel, vTv Alzheimer's Trial Results",2018-05-10 09:44:00-04:00,CDNA,neutral
225829.0,"The Week Ahead In Biotech: PDUFA Dates, Earnings, IPOs And More",2018-05-06 18:19:00-04:00,CDNA,neutral
225830.0,"Benzinga's Daily Biotech Pulse: SIGA Rallies On FDA Panel Backing, Rigel And Gilead React To Earnings",2018-05-02 07:41:00-04:00,CDNA,neutral
225831.0,Form 4 Filing Late Monday Shows CareDx 10% Owner Bought 10.136K Shares at $9.42,2018-05-01 11:16:00-04:00,CDNA,positive
225832.0,"Benzinga's Daily Biotech Pulse: Karyopharm's STORM Study, Inogen Rallies On Earnings",2018-05-01 07:51:00-04:00,CDNA,neutral
225833.0,"Cadence Design Raises FY18 Sales Outlook From $2.015B-$2.055B As Of Jan. 31, '18 To $2.085B-$2.115B vs $2.04B Est.",2018-04-23 16:10:00-04:00,CDNA,neutral
225834.0,CareDx Reports Olerup QTYPE Human Leukocyte Antigen Typing Diagnostic Received CE Mark Approval,2018-04-13 08:06:00-04:00,CDNA,positive
225835.0,CareDx Launches HeartCare for Heart Transplant Recipients,2018-04-10 08:05:00-04:00,CDNA,neutral
225836.0,42 Biggest Movers From Friday,2018-03-26 05:13:00-04:00,CDNA,neutral
225837.0,Mid-Afternoon Market Update: CareDx Rises Following Q4 Results; PLx Pharma Shares Plummet,2018-03-23 14:32:00-04:00,CDNA,positive
225838.0,30 Stocks Moving In Friday's Mid-Day Session,2018-03-23 13:10:00-04:00,CDNA,neutral
225839.0,CareDx Shares Up 21.2% After Co. Thursday Reported Better-Than-Expected Q4 Loss,2018-03-23 13:05:00-04:00,CDNA,neutral
225840.0,Mid-Day Market Update: At Home Group Gains On Upbeat Earnings; Resonant Shares Slide,2018-03-23 13:03:00-04:00,CDNA,positive
225841.0,Mid-Morning Market Update: Markets Mixed; Nike Tops Q3 Expectations,2018-03-23 10:21:00-04:00,CDNA,positive
225842.0,CareDX Sees FY18 Sales $61M-$63M vs $61.5M Est.,2018-03-22 16:03:00-04:00,CDNA,neutral
225843.0,"CareDX Q4 Adj. EPS $(0.09) Beats $(0.14) Est., Sales $12.5M Beats $12.25M Est.",2018-03-22 16:03:00-04:00,CDNA,neutral
225844.0,"Earnings Scheduled For March 22, 2018",2018-03-22 04:40:00-04:00,CDNA,neutral
225845.0,CareDx Reports First Patient Enrolled In AlloSure Registry,2018-02-01 08:09:00-05:00,CDNA,neutral
225846.0,CareDx Sees Q4 Sales $12.3M-$12.5M vs $12M Est.; Sees FY17 Sales $48.1M-$48.3M vs $47.9M Est.,2018-01-08 08:37:00-05:00,CDNA,neutral
225847.0,"Shares of CareDx Spike To High Of $7.88 Before Pulling Back To $7.48/Share Level, Up 2.9% On Day",2017-12-29 14:39:00-05:00,CDNA,positive
225848.0,"CareDx Shares Spike Into Positive Territory Over Last Min., Now Up 3.5%; Not Yet Seeing News To Justify Spike Higher",2017-12-29 14:39:00-05:00,CDNA,positive
225849.0,45 Biggest Movers From Yesterday,2017-11-28 05:21:00-05:00,CDNA,neutral
225850.0,34 Stocks Moving In Monday's Mid-Day Session,2017-11-27 12:25:00-05:00,CDNA,neutral
225851.0,"Benzinga's Top Upgrades, Downgrades For November 27, 2017",2017-11-27 09:05:00-05:00,CDNA,positive
225852.0,32 Stocks Moving In Monday's Pre-Market Session,2017-11-27 08:03:00-05:00,CDNA,neutral
225853.0,"H.C. Wainwright Initiates Coverage On CareDx with Buy Rating, Announces $12.00 Price Target",2017-11-27 07:08:00-05:00,CDNA,neutral
225854.0,"CareDx Reports Q3 EPS $(0.63) vs. $(0.15) vs. $(0.17) Est., Sales $12.2M vs. $12.05M Est.",2017-11-09 16:04:00-05:00,CDNA,neutral
225855.0,28 Stocks Moving In Monday's Pre-Market Session,2017-10-09 08:08:00-04:00,CDNA,neutral
225856.0,Mid-Afternoon Market Update: Dow Rises Over 100 Points; NeoPhotonics Shares Slide,2017-10-05 14:31:00-04:00,CDNA,positive
225857.0,16 Biggest Mid-Day Gainers For Thursday,2017-10-05 12:41:00-04:00,CDNA,neutral
225858.0,Mid-Day Market Update: Onvia Climbs On Acquisition News; Intellicheck Shares Plummet,2017-10-05 12:14:00-04:00,CDNA,positive
225859.0,CareDx's Lower Priced Stock Offering Attracts Buyers At Higher Prices,2017-10-05 11:34:00-04:00,CDNA,positive
225860.0,CareDx Shares 15.% Premarket @$5.11; Co Priced 4.3M Share Offering @$4.00/Share,2017-10-05 08:16:00-04:00,CDNA,positive
225861.0,15 Biggest Mid-Day Gainers For Tuesday,2017-10-03 12:09:00-04:00,CDNA,neutral
225862.0,Amended S-1 From CareDx Shows Offering For 3.6M Shares Of Common Stock,2017-10-02 16:13:00-04:00,CDNA,positive
225863.0,20 Biggest Mid-Day Losers For Wednesday,2017-09-27 13:31:00-04:00,CDNA,negative
225864.0,"Benzinga's Top Upgrades, Downgrades For September 27, 2017",2017-09-27 09:18:00-04:00,CDNA,positive
225865.0,25 Stocks Moving In Wednesday's Pre-Market Session,2017-09-27 08:06:00-04:00,CDNA,neutral
225866.0,Raymond James Upgrades CareDx to Outperform,2017-09-27 07:09:00-04:00,CDNA,neutral
225867.0,18 Biggest Mid-Day Gainers For Tuesday,2017-09-26 12:37:00-04:00,CDNA,neutral
225868.0,CareDX Files For 3M Share Offering Common Stock,2017-09-01 16:57:00-04:00,CDNA,positive
225869.0,10 Biggest Mid-Day Losers For Monday,2017-08-28 12:55:00-04:00,CDNA,negative
225870.0,18 Biggest Mid-Day Gainers For Friday,2017-08-25 12:17:00-04:00,CDNA,neutral
225871.0,22 Stocks Moving In Friday's Pre-Market Session,2017-08-25 08:02:00-04:00,CDNA,neutral
225872.0,"CareDx Confirms AlloSure Will Receive Medicare Coverage Effective Oct. 9th, 2017",2017-08-24 13:11:00-04:00,CDNA,positive
225873.0,CareDx Sees FY17 Sales $46M-$49M,2017-08-10 16:37:00-04:00,CDNA,neutral
225874.0,"CareDx Reports Q2 Loss/Share $(0.17) vs. $(0.19) Est., Sales $12M vs. $11.8M Est.",2017-08-10 16:18:00-04:00,CDNA,neutral
225875.0,18 Biggest Mid-Day Gainers For Wednesday,2017-07-26 12:21:00-04:00,CDNA,neutral
225876.0,"CareDx Shares Up 33.6% On No News; Very Small Insider Purchase Was Disclosed Tues. Night, However That News Is Not Likely Justifying Wed. Price Action; $1.15 Level Was Notable Support Area Earlier In Jul.",2017-07-26 10:11:00-04:00,CDNA,positive
225877.0,"Caredx 10%+ Owner  Neil  GagnonBuys 63,120 @ Avg Price: $1.10 -Form4",2017-06-27 10:14:00-04:00,CDNA,neutral
225878.0,"CareDx Reports Q1 EPS $(0.32) vs $(0.22) Est., Sales $11.6M vs $11.3M Est.",2017-06-09 08:32:00-04:00,CDNA,neutral
225879.0,CareDx Announces Receipt Of Non-compliance Letter From Nasdaq For Non-Timely 10-Q Filing,2017-05-22 17:45:00-04:00,CDNA,neutral
225880.0,CareDx Sees FY17 Sales $45M-$50M vs $46M Est.,2017-05-22 16:08:00-04:00,CDNA,neutral
225881.0,"CareDx Reports Prelim. Results: Sees Q1 Sales $11.4M-$11.6M vs $11.3M Est., EPS $(0.32)-$(0.27) vs $(0.19) Est.",2017-05-22 16:08:00-04:00,CDNA,neutral
225882.0,"Earnings Scheduled For May 22, 2017",2017-05-22 05:03:00-04:00,CDNA,neutral
225883.0,"Earnings Scheduled For March 31, 2017",2017-03-31 04:46:00-04:00,CDNA,neutral
225884.0,Mid-Afternoon Market Update: Oracle Gains On Earnings Beat; TrovaGene Shares Slide,2017-03-16 15:23:00-04:00,CDNA,positive
225885.0,18 Biggest Mid-Day Losers For Thursday,2017-03-16 13:10:00-04:00,CDNA,negative
225886.0,Mid-Day Market Update: U.S. Stocks Turn Negative; GoPro Shares Spike Higher,2017-03-16 12:17:00-04:00,CDNA,negative
225887.0,CareDx Sees FY17 Sales $45M-$50M vs $52.3M Est.,2017-03-15 16:05:00-04:00,CDNA,neutral
225888.0,CareDx Reports Prelim. Q4 Sales $10.6M-$10.9M vs $12M Est.; FY16 Sales $40.4M-$40.7M vs $41.5M Est.,2017-03-15 16:05:00-04:00,CDNA,neutral
225889.0,CareDx To Acquire SBT Resolver HLA Typing Products From Illumina,2017-01-24 16:57:00-05:00,CDNA,positive
225890.0,10 Biggest Mid-Day Gainers For Wednesday,2016-12-28 12:27:00-05:00,CDNA,neutral
225891.0,"Top Performing Industries For December 12, 2016",2016-12-12 10:44:00-05:00,CDNA,positive
225892.0,12 Biggest Mid-Day Gainers For Tuesday,2016-11-22 13:36:00-05:00,CDNA,neutral
225893.0,"CMS Announces CLFS for 2017 – CareDx's AlloMap Reimbursement Updated; Rate to Remain at $2,821",2016-11-21 21:33:00-05:00,CDNA,neutral
225894.0,UPDATE: CareDx Says 'Assay has sensitivity of 59% and specificity of 85% at a 1% threshold',2016-11-18 15:04:00-05:00,CDNA,neutral
225895.0,CareDx Reports AlloSure Has Detected Active Rejection in Kidney Transplant Patients,2016-11-18 15:03:00-05:00,CDNA,negative
225896.0,CareDx Files for Non-Timely 10-Q,2016-11-15 17:09:00-05:00,CDNA,neutral
225897.0,"CareDX Reports Q3 non-GAAP Loss/Share $0.15 vs Est Loss/Share $0.25, Rev $12.5M vs $11.5M Est",2016-11-09 16:02:00-05:00,CDNA,neutral
225898.0,CareDX Reports First Commercial Sale Of Olerup QTYPE,2016-10-24 16:01:00-04:00,CDNA,neutral
225899.0,"Worst Performing Industries For October 11, 2016",2016-10-11 11:02:00-04:00,CDNA,negative
225900.0,"Three CareDx Insiders Each Acquire 10,000 Shares At $4 As Of Sept. 26 - Form4",2016-10-05 07:57:00-04:00,CDNA,positive
225901.0,Mid-Afternoon Market Update: Dow Surges 125 Points; FedEx Shares Jump Following Upbeat Earnings,2016-09-21 15:26:00-04:00,CDNA,positive
225902.0,12 Biggest Mid-Day Losers For Wednesday,2016-09-21 13:03:00-04:00,CDNA,negative
225903.0,Mid-Day Market Update: Crude Oil Up 2.75%; Mast Therapeutics Shares Drop After Sickle Cell Drug Phase 3 Trial Fail,2016-09-21 12:16:00-04:00,CDNA,negative
225904.0,CareDx: Strange Timing For A Share Offering,2016-09-21 10:54:00-04:00,CDNA,positive
225905.0,Mid-Morning Market Update: Markets Open Higher; General Mills Earnings Top Views,2016-09-21 10:05:00-04:00,CDNA,positive
225906.0,CareDx Prices 2.25M Share Offering At $4/Share,2016-09-21 09:00:00-04:00,CDNA,positive
225907.0,20 Stocks Moving In Wednesday's Pre-Market Session,2016-09-21 08:31:00-04:00,CDNA,neutral
225908.0,CareDx Reports Proposed Public Offering of Common Stock,2016-09-20 16:01:00-04:00,CDNA,neutral
225909.0,CareDx Files Non-Timely 10Q,2016-08-16 08:13:00-04:00,CDNA,positive
225910.0,CareDx Sees FY16 Rev. $40-$42M vs. Est. $40M,2016-08-10 16:05:00-04:00,CDNA,neutral
225911.0,"CareDx Reports Prelim Q2 EPS $(0.29) vs. Est. $(0.28), Rev. $10.7M vs. Est. $10.4M",2016-08-10 16:04:00-04:00,CDNA,neutral
225912.0,CareDx Calls For Medicare Administrative Contractor First Coast Service Options To Reverse Recent Proposal To Drastically Reduce Reimbursement For FDA-Cleared Diagnostic Test AlloMap,2016-07-13 15:04:00-04:00,CDNA,neutral
225913.0,"CareDx Responds To CMS Proposal, Will Cut AlloMap Pricing By 74%",2016-06-29 08:04:00-04:00,CDNA,negative
225914.0,CareDx Reported Positive Clinical Results For Its Kidney Transplant Blood Tests,2016-06-15 17:47:00-04:00,CDNA,positive
225915.0,"CareDx, QIAGEN Enter Into Commercial Partnership to Enhance HLA Lab Experience Using QIAxcel Instrumentation and CareDx HLA Typing Technology",2016-05-31 08:01:00-04:00,CDNA,neutral
225916.0,CareDx Reports Closing of Enrollment in Multicenter Kidney Transplant Study to Validate Cell-Free DNA Technology,2016-05-27 16:05:00-04:00,CDNA,positive
225917.0,CareDx Sees FY16 Rev. $40-$42M vs. Est. $37M,2016-05-06 07:34:00-04:00,CDNA,neutral
225918.0,CareDx Reports Q1 EPS $(0.37) vs. Est. $(0.31),2016-05-06 07:33:00-04:00,CDNA,neutral
225919.0,UPDATE: Caredx Says Co Entered Securities Purchase Agreement Of $14.1M In Unit On April 12th,2016-04-14 16:19:00-04:00,CDNA,positive
225920.0,Caredx Announces $22M Private Placement,2016-04-14 16:15:00-04:00,CDNA,neutral
225921.0,CareDx Names Todd Whitson New Chief Commercial Officer,2016-03-29 13:05:00-04:00,CDNA,neutral
225922.0,"CareDx Names Charles Constanti CFO, Replacing Ken Ludlum",2016-03-24 16:02:00-04:00,CDNA,neutral
225923.0,"CareDx Reports Q4 EPS $(0.40) vs. Est. $(0.34), Rev. $6.6M vs. Est. $7.44M",2016-03-24 16:01:00-04:00,CDNA,neutral
225924.0,"Earnings Scheduled For March 24, 2016",2016-03-24 04:06:00-04:00,CDNA,neutral
225925.0,"CareDx Says Required Additional Reviews by Swedish, U.S. Auditors, Approval of Prospectus in Bid to Acquire Allenex AB Now Expected by March 7, 2016",2016-02-29 04:16:00-05:00,CDNA,positive
225926.0,"Janney Initiates CareDx With Buy Rating, $12 Target",2016-02-10 10:24:00-05:00,CDNA,neutral
225927.0,Benzinga's Top Initiations,2016-02-10 09:46:00-05:00,CDNA,positive
225928.0,Janney Capital Initiates Coverage on CareDx at Buy,2016-02-10 06:16:00-05:00,CDNA,neutral
225929.0,CareDx Announces Revised Agreement to Purchase 78% Outstanding Shares of Allenex AB,2016-02-09 03:59:00-05:00,CDNA,positive
225930.0,"CareDx Reports Q3 EPS $(0.29) Vs Est $(0.25), Sales $7.15M Vs Est $7.34M",2015-11-11 16:06:00-05:00,CDNA,neutral
225931.0,CareDx Announces Reversal of Recent Proposal by CMS to Drasically Reduce Reimbursement for FDA-Cleared AlloMap,2015-10-08 12:41:00-04:00,CDNA,neutral
225932.0,Raymond James Downgrades CareDx to Market Perform,2015-09-28 13:17:00-04:00,CDNA,neutral
225933.0,CareDx Responds to Proposed CMS Clinical Laboratory Fee Schedule Changes,2015-09-28 06:31:00-04:00,CDNA,neutral
225934.0,Benzinga's Top Initiations,2015-09-25 09:29:00-04:00,CDNA,positive
225935.0,"Craig-Hallum Initiates Coverage on CareDx at Buy, Announces $13.00 PT",2015-09-25 08:17:00-04:00,CDNA,neutral
225936.0,"Neil Gagnon Buys 69,383 Shares of Caredx @$6.95/Share -Form 4",2015-09-09 11:29:00-04:00,CDNA,positive
225937.0,5 Biotechs Leerink Analysts Are Watching,2015-08-11 14:23:00-04:00,CDNA,neutral
225938.0,"CareDx Reports Q2 Sales $7.1M vs $7.3M Est., Loss of $0.27/Share vs Loss of $0.18/Share Est.; Sees FY15 Sales $28M-$30M vs $29.6M Est.",2015-08-10 16:21:00-04:00,CDNA,negative
225939.0,S-3 from CareDx Shows Registration for $75M Mixed Securities Shelf Offering,2015-08-10 16:20:00-04:00,CDNA,positive
225940.0,13G Filing from Intel on CareDx Shows New 5% Stake,2015-08-07 16:10:00-04:00,CDNA,neutral
225941.0,Top 4 Small-Cap Stocks In The Research Services Industry With The Highest ROI,2015-07-02 05:22:00-04:00,CDNA,positive
225942.0,"MaxLinear, PowerSecure, Alaska Air Lead After-Hours Movers To Close The Week",2015-06-06 14:40:00-04:00,CDNA,neutral
225943.0,"CareDx, Horizon Discovery Group Enter into Collaboration to Develop Cell-Free DNA Reference Standards",2015-06-03 06:06:00-04:00,CDNA,neutral
225944.0,"CareDx Reports Q1 Loss $0.19 Vs Loss $0.18, Sales $7.22M Vs Est $6.83M",2015-05-12 16:07:00-04:00,CDNA,negative
225945.0,"Earnings Scheduled For May 12, 2015",2015-05-12 04:10:00-04:00,CDNA,neutral
225946.0,CareDx Cell-Free DNA (cfDNA) Biomarker Combined With AlloMap(R) Increases Accuracy of Identification of Rejection in Heart,2015-04-16 11:03:00-04:00,CDNA,negative
225947.0,Stocks Hitting 52-Week Lows,2015-04-10 10:28:00-04:00,CDNA,negative
225948.0,CareDx to Announce New Data on AlloMap(R) and Cell-Free DNA (cfDNA) Biomarker in Heart Transplant Recipients at ISHLT 2015,2015-04-08 16:06:00-04:00,CDNA,neutral
225949.0,"Caredx Shareholder Gagnon Buys 6,324 @$6.35/Share -Form 4",2015-03-23 13:33:00-04:00,CDNA,neutral
225950.0,"CareDx Reports Q4 Breakeven, Sales $8M vs $6.86M Est.",2015-03-17 16:06:00-04:00,CDNA,neutral
225951.0,"Earnings Scheduled For March 17, 2015",2015-03-17 05:03:00-04:00,CDNA,neutral
225952.0,CareDx Appoints William A. Hagstrom to Its Board of Directors,2015-03-03 16:11:00-05:00,CDNA,neutral
225953.0,Top 4 Small-Cap Stocks In The Research Services Industry With The Highest Gross Margin,2015-02-19 04:14:00-05:00,CDNA,negative
225954.0,CareDx Secures $20M Term Loan With East West Bank,2015-02-03 16:27:00-05:00,CDNA,positive
225955.0,DIAXONHIT Announces Strasbourg U Hospital to Become European Central Lab for Processing CareDx AlloMap Heart Transplant Tests,2015-01-12 04:37:00-05:00,CDNA,neutral
225956.0,CareDx Announces Positive Coverage Decision for AlloMap from Two Added Medicare Administrative Carrier Jurisdictions,2015-01-07 08:05:00-05:00,CDNA,positive
225957.0,From 13D: Merckle Intl. On CAREDEX Shows New 5% Stake,2014-11-21 15:27:00-05:00,CDNA,neutral
225958.0,"Worst Performing Industries For November 20, 2014",2014-11-20 11:01:00-05:00,CDNA,negative
225959.0,CareDx Reports Q3 EPS of $0.12 vs $(0.13) Est; Revenue of $6.70M vs $6.63M Est,2014-11-10 16:21:00-05:00,CDNA,neutral
225960.0,SC 13G Filed By James Flynn Shows 6.82% Passive Stake ,2014-10-10 13:06:00-04:00,CDNA,positive
225961.0,"CareDx Reports Q2 EPS $0.13, Sales $6.8M",2014-08-27 16:07:00-04:00,CDNA,neutral
225962.0,Benzinga's Top Initiations,2014-08-11 09:08:00-04:00,CDNA,positive
225963.0,CareDx's 3-Part Bull & 3-Part Bear Cases,2014-08-11 08:35:00-04:00,CDNA,neutral
225964.0,Piper Jaffray Initiates CareDx With Overweight,2014-08-11 08:35:00-04:00,CDNA,negative
225965.0,"Leerink Swann Initiates Coverage on CareDx at Outperform, Announces $13.00 PT",2014-08-11 06:49:00-04:00,CDNA,neutral
225966.0,3 Analysts Start Coverage Of CareDX,2014-08-11 06:42:00-04:00,CDNA,neutral
225967.0,"Shares of CareDx Open for Trade at $9.50, IPO Priced at $10/Share",2014-07-17 10:59:00-04:00,CDNA,positive
225968.0,Waiting on 3 IPOs This Morning,2014-07-17 09:21:00-04:00,CDNA,neutral
225969.0,9 IPOs To Watch For This Week,2014-07-14 11:06:00-04:00,CDNA,neutral
225970.0,CareDx Expects 3.125M Share IPO to Price $15.00-$17.00/Share,2014-07-07 06:17:00-04:00,CDNA,positive
